The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2025

Filed:

Apr. 11, 2023
Applicant:

Axsonus Llc, San Antonio, TX (US);

Inventors:

Jason Bourgeois, San Antonio, TX (US);

Michael L. Wach, Alpharetta, GA (US);

Frank Lau, New Orleans, LA (US);

Assignee:

Axsonus LLC, San Antonio, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 17/11 (2006.01); A61B 5/00 (2006.01); A61B 17/02 (2006.01); A61M 5/142 (2006.01); A61N 1/05 (2006.01); A61N 1/20 (2006.01); A61N 1/36 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61B 90/00 (2016.01); A61K 45/06 (2006.01); A61N 1/32 (2006.01); C07K 14/475 (2006.01);
U.S. Cl.
CPC ...
A61B 17/1128 (2013.01); A61B 5/4041 (2013.01); A61B 17/0218 (2013.01); A61M 5/142 (2013.01); A61N 1/0551 (2013.01); A61N 1/205 (2013.01); A61N 1/36071 (2013.01); A61B 2017/00022 (2013.01); A61B 2017/00398 (2013.01); A61B 2017/1103 (2013.01); A61B 2017/1132 (2013.01); A61B 17/3468 (2013.01); A61B 90/03 (2016.02); A61B 2090/064 (2016.02); A61K 45/06 (2013.01); A61L 2300/414 (2013.01); A61L 2430/32 (2013.01); A61L 2430/38 (2013.01); A61N 1/326 (2013.01); C07K 14/475 (2013.01);
Abstract

To achieve in vivo repair of severed mammalian nerve tissue, a system can be employed to induce distraction neurogenesis. At least a portion of the system can be anchored at an injury site, such as between distal and proximal nerve ends. The system can be attached to the proximal nerve end and can place the nerve under micro-tension for an extended period of treatment. The system may also deliver medication or treatment to encourage neurogenesis and to reduce pain in the subject receiving treatment. After the course of treatment, the device can be removed from the injury site, and the nerve ends rejoined.


Find Patent Forward Citations

Loading…